Madden Securities’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-9,131
Closed -$303K 98
2023
Q3
$303K Buy
9,131
+1,967
+27% +$69.6K 0.17% 73
2023
Q2
$263K Buy
7,164
+1,860
+35% +$72.4K 0.13% 79
2023
Q1
$216K Sell
5,304
-218
-4% -$9.42K 0.11% 84
2022
Q4
$283K Sell
5,522
-847
-13% -$40.6K 0.15% 82
2022
Q3
$279K Sell
6,369
-77
-1% -$3.74K 0.17% 83
2022
Q2
$338K Sell
6,446
-347
-5% -$17.7K 0.19% 80
2022
Q1
$352K Sell
6,793
-44,129
-87% -$2.29M 0.16% 81
2021
Q4
$3.01M Sell
50,922
-227
-0.4% -$11.2K 1.41% 25
2021
Q3
$2.2M Sell
51,149
-2,558
-5% -$113K 1.19% 33
2021
Q2
$2.1M Buy
53,707
+40
+0.1% +$1.56K 1.1% 29
2021
Q1
$1.94M Sell
53,667
-1,765
-3% -$62.7K 1.14% 27
2020
Q4
$2.04M Buy
55,432
+21,250
+62% +$779K 1.31% 21
2020
Q3
$1.19M Buy
34,182
+1,509
+5% +$52.9K 0.88% 33
2020
Q2
$1.01M Buy
+32,673
New +$1.11M 0.9% 32
2019
Q4
$561K Buy
+15,062
New +$536K 0.56% 50

Other funds holding PFE

Madden Securities's PFE Position: Q4 2023 in Review

Madden Securities sold out of Pfizer (PFE) in Q4 2023, closing a stake of 9,131 shares — an estimated $303K sold.

Madden Securities first reported a position in PFE in Q4 2019 and held it in 15 quarters. The position peaked at $3.01M in Q4 2021. 2,935 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

  • Madden Securities reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
  • Madden Securities sold 9,131 Pfizer shares in Q4 2023, an estimated $303K.
  • Madden Securities first reported a position in Pfizer in Q4 2019 and held it in 15 quarters.
  • Madden Securities's Pfizer position peaked at $3.01M in Q4 2021.
  • 2,935 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on Madden Securities's 13F filing for Q4 2023, filed 13 Feb 2024.